253 related articles for article (PubMed ID: 19350105)
21. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection.
Shimizu M; Tropak M; Diaz RJ; Suto F; Surendra H; Kuzmin E; Li J; Gross G; Wilson GJ; Callahan J; Redington AN
Clin Sci (Lond); 2009 Aug; 117(5):191-200. PubMed ID: 19175358
[TBL] [Abstract][Full Text] [Related]
22. The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.
Hausenloy DJ; Chilian W; Crea F; Davidson SM; Ferdinandy P; Garcia-Dorado D; van Royen N; Schulz R; Heusch G
Cardiovasc Res; 2019 Jun; 115(7):1143-1155. PubMed ID: 30428011
[TBL] [Abstract][Full Text] [Related]
23. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
Pagel PS; Krolikowski JG
Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
[TBL] [Abstract][Full Text] [Related]
24. Cardiac protection takes off.
Piper HM; Garcia-Dorado D
Cardiovasc Res; 2009 Jul; 83(2):163-4. PubMed ID: 19509028
[No Abstract] [Full Text] [Related]
25. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
Skyschally A; Schulz R; Heusch G
Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
[TBL] [Abstract][Full Text] [Related]
26. Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations.
Monassier JP
Arch Cardiovasc Dis; 2008; 101(7-8):491-500. PubMed ID: 18848692
[TBL] [Abstract][Full Text] [Related]
27. Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion.
García-Dorado D; Rodríguez-Sinovas A; Ruiz-Meana M
Cardiovasc Res; 2004 Feb; 61(3):386-401. PubMed ID: 14962471
[TBL] [Abstract][Full Text] [Related]
28. BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts.
Krieg T; Liu Y; Rütz T; Methner C; Yang XM; Dost T; Felix SB; Stasch JP; Cohen MV; Downey JM
Eur Heart J; 2009 Jul; 30(13):1607-13. PubMed ID: 19406872
[TBL] [Abstract][Full Text] [Related]
29. Phosphodiesterase 5 inhibitors: are they cardioprotective?
Reffelmann T; Kloner RA
Cardiovasc Res; 2009 Jul; 83(2):204-12. PubMed ID: 19474180
[TBL] [Abstract][Full Text] [Related]
30. Inhalational anaesthetics and cardioprotection.
Weber NC; Schlack W
Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
[TBL] [Abstract][Full Text] [Related]
31. Natriuretic peptides and myocardial ischaemia.
Baxter GF
Basic Res Cardiol; 2004 Mar; 99(2):90-3. PubMed ID: 14963667
[TBL] [Abstract][Full Text] [Related]
32. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction.
Cannon RO
Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):88-94. PubMed ID: 16265379
[TBL] [Abstract][Full Text] [Related]
34. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
[TBL] [Abstract][Full Text] [Related]
35. Fighting the "fire" of myocardial reperfusion injury: how to define success?
Wu KC
J Am Coll Cardiol; 2009 Feb; 53(8):730-1. PubMed ID: 19232908
[No Abstract] [Full Text] [Related]
36. [Postconditioning in acute myocardial infarction: Primary angioplasty revisited?].
Monassier JP; Shayne J; Sommier JM; Schultz R; Ider O
Ann Cardiol Angeiol (Paris); 2010 Nov; 59(5):294-305. PubMed ID: 20889138
[TBL] [Abstract][Full Text] [Related]
37. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?
Lecour S
J Mol Cell Cardiol; 2009 Jul; 47(1):32-40. PubMed ID: 19344728
[TBL] [Abstract][Full Text] [Related]
38. The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging.
Kato M; Akao M; Matsumoto-Ida M; Makiyama T; Iguchi M; Takeda T; Shimizu S; Kita T
Cardiovasc Res; 2009 Jul; 83(2):335-44. PubMed ID: 19299432
[TBL] [Abstract][Full Text] [Related]
39. Lethal myocardial reperfusion injury: a necessary evil?
Ibanez B; Fuster V; Jiménez-Borreguero J; Badimon JJ
Int J Cardiol; 2011 Aug; 151(1):3-11. PubMed ID: 21093938
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury.
Ruiz-Meana M; Rodríguez-Sinovas A; Cabestrero A; Boengler K; Heusch G; Garcia-Dorado D
Cardiovasc Res; 2008 Jan; 77(2):325-33. PubMed ID: 18006437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
